Agents of the tribe Ehrlichiae cause a variety of tick-borne diseases in both humans and animals. Many of these agents persist in the host thus acting as potential reservoirs for further spread of disease. Anaplasma marginale is closely related genetically (16S rRNA) with E. phagocytophila, the causative agent of human granulocytic ehrlichiosis (HGE). Indeed, both organisms express antigenically variant outer membrane proteins, major surface protein-2 (MSP-2) that share significant amino acid sequence conservation characterized by highly conserved N and C terminal regions and a central, hydrophilic, hypervariable region. Levels of rickettsemia during persistent anaplasmosis are approximately two orders of magnitude less than rickettsemia levels during acute infection and do not result in clinical disease. We hypothesize that the control of rickettsemia to levels significantly below those observed during acute clinical anaplasmosis is due to a memory CD4+ Th-cell response to conserved epitopes on MSP-2 that enhance variant specific B cell responses directed against the hypervariable region. The results of this research will provide insight into means of developing outer membrane protein-based vaccines against A. marginale and other ehrlichial organisms that cause disease in animals and humans, especially the closely related agent of HGE, E. phagocytophila
| Brown, Wendy C; Norimine, Junzo; Knowles, Donald P et al. (2006) Immune control of Babesia bovis infection. Vet Parasitol 138:75-87 |
| Abbott, Jeffrey R; Palmer, Guy H; Kegerreis, Kimberly A et al. (2005) Rapid and long-term disappearance of CD4+ T lymphocyte responses specific for Anaplasma marginale major surface protein-2 (MSP2) in MSP2 vaccinates following challenge with live A. marginale. J Immunol 174:6702-15 |
| Abbott, Jeffrey R; Palmer, Guy H; Howard, Chris J et al. (2004) Anaplasma marginale major surface protein 2 CD4+-T-cell epitopes are evenly distributed in conserved and hypervariable regions (HVR), whereas linear B-cell epitopes are predominantly located in the HVR. Infect Immun 72:7360-6 |
